http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5361a484d509ef13613c7142dea502de
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Borghaei |
| name | Hossein Borghaei |
| given-name | Hossein |
| organization-name | Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania. Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA. Fox Chase Cancer Center , Philadelphia, PA , USA From the Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR; M. D. Anderson Cancer Center, Houston, TX; University of North Carolina at Chapel Hill, Chapel Hill, NC; Weill Cornell Medical College, New York, NY; Winship Cancer Institute, Atlanta, GA; Fox Chase Cancer Center, Philadelphia; Ortho Biotech Oncology R&D, Malvern, PA; H. Lee Moffitt Cancer and Research Institute, Tampa, FL; and Fred Hutchinson Cancer Research Center, Seattle, WA. Department of Hematology/Oncology Fox Chase Cancer Center Philadelphia Pennsylvania From the Sarah Cannon Research Institute, Nashville, TN; Cleveland Clinic, Cleveland, OH; Fox Chase Cancer Center, Philadelphia, PA Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA Department of Medical Oncology Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA Departments of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA From Memorial Sloan Kettering Cancer Center Hospital, New York (M.D.H.); Prof. Dr. Ion Chiricuta Institute of Oncology and Universitatea de Medicina si Farmacie Iuliu Hatieganu, Cluj-Napoca, Romania (T.-E.C.); Centrum Onkologii–Instytut im. Marii Sklodowskiej-Curie, Warsaw, Poland (A.P.); Seoul National University Bundang Hospital, Seoul, South Korea (J.S.L.); Ohio State University, Columbus (G.A.O.); Hôpital Sainte Musse, Toulon, France (C.A.-V.); Ospedale Santa Maria della Misericordia, Perugia, Italy ... Departments of Hematology/Oncology Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA From the University of Texas M.D. Anderson Cancer Center, Houston (F.S.), and U.S. Oncology Research, the Woodlands (A. Spira) — both in Texas; Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine (B.T.L.) and Thoracic Medical Oncology, Perlmutter Cancer Center, New York University (V.V.), New York, and Roswell Park Cancer Institute, Buffalo (G.K.D.) — all in New York; the Queen Elizabeth Hospital and University of Adelaide, Woodville, SA, Australia (T.J.P.); Sarah Cannon Research Institute... 1Department of Hematology-Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania. Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, 19111;; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111 Leora Horn, Vanderbilt-Ingram Cancer Center; David R. Spigel, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Everett E. Vokes, University of Chicago, Chicago, IL; Esther Holgado, Hospital De Madrid, Norte Sanchinarro, Madrid; Enriqueta Felip, Hospital Universitari Vall d’Hebron, Barcelona; Luis Paz-Ares, Hospital Universitario Virgen Del Rocio, Seville, Spain; Neal Ready, Duke University Medical Center, Durham, NC; Martin Steins, Thoraxklinik-Heidelberg gGmbH, Heidelberg; Martin... Fox Chase Cancer Center, Philadelphia, PA, USA. Authors' Affiliations: 1M.D. Anderson Cancer Center, University of Texas, Houston, Texas; 2Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 3Fred Hutchinson Cancer Research Center, Seattle, Washington; 4Weill Cornell Medical College and New York Presbyterian Hospital; 5Mount Sinai Medical Center, New York, New York; 6Winship Cancer Institute, Emory University, Atlanta, Georgia; 7Fox Chase Cancer Center, Philadelphia; 8Janssen Research & Development, LLC, Spring House; 9Janssen Research & Development, LLC, Radnor, Pennsylvania; 10H. Lee Moffitt Cancer & Research Institute, Tampa, Florida; 11Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas; and 12Janssen Research & Development, Beerse, Belgium Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 2Fox Chase Cancer Center, Philadelphia, Pennsylvania. Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA Naiyer A. Rizvi and Matthew D. Hellmann, Memorial Sloan Kettering Cancer Center, New York, NY; Julie R. Brahmer, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Rosalyn A. Juergens, Juravinski Cancer Centre at McMaster University, Hamilton; Scott A. Laurie, Ottawa Hospital Cancer Centre, Ottawa; Frances A. Shepherd, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Hossein Borghaei, Fox Chase Cancer Center, Philadelphia, PA; Scott Gettinger, Yale Cancer Center, New... From the Department of Medical Oncology, and the Protocol Supportive Laboratory, Fox Chase Cancer Center, Philadelphia, PA; Active Biotech, Lund, Sweden; Christie Research Centre, Manchester, United Kingdom; the Department of Clinical Cancer Research, Norwegian Radium Hospital, Oslo, Norway; and the Department of Oncology, Rikshospitalet University Hospital, Copenhagen, Denmark. 3Fox Chase Cancer Center, Philadelphia, Pennsylvania. Division of Thoracic Medical Oncology, Department of Hematology/Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA Fox Chase Cancer Center, Philadelphia, PA From the Memorial Sloan Kettering Cancer Center, New York (M.D.H.); Hospital Universitario Doce de Octubre, Centro Nacional de Investigaciones Oncológicas, Universidad Complutense, and Centro de Investigación Biomédica en Red de Cáncer, Madrid (L.P.-A.), Hospital Universitario Virgen Del Rocio, Seville (R.B.C.), and the Catalan Institute of Oncology–Germans Trias i Pujol Hospital, Badalona (E.C.C.) — all in Spain; Ambulatorium Chemioterapii, Bydgoszcz, Poland (B.Z.); the Asan Medical Center (S.-W.K.) and... Authors' Affiliations: 1Ludwig Center at Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts; 2Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico-Istituto Nazionale dei Tumori, Milan, Italy; 3Centre Léon Bérard, Departement de Medecine, Lyon, France; 4Fox Chase Cancer Center, Philadelphia, Pennsylvania; 5Helios Klinikum Bad Saarow, Department of Hematology, Oncology and Palliative Medicine, Bad Saarow, Germany; 6Center for Human Genetics, Catholic University of Leuven, Leuven, Belgium; 7Novartis Pharmaceuticals AG, Basel, Switzerland; and 8Helios Klinikum Berlin-Buch, Sarcoma Center, Berlin, Germany Scott Gettinger, Yale Cancer Center, New Haven, CT; Naiyer A. Rizvi and Matthew D. Hellmann, Memorial Sloan Kettering Cancer Center, New York, NY; Laura Q. Chow, University of Washington, Seattle, WA; Hossein Borghaei, Fox Chase Cancer Center, Philadelphia, PA; Julie Brahmer, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Neal Ready, Duke University Medical Center, Durham, NC; David E. Gerber, University of Texas Southwestern Medical Center, Dallas, TX; Frances A. Shepherd... |
Incoming Links
Total number of triples: 144.